MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/antibiotics15040342

Медицинская библиотека · Antibiotics (Basel, Switzerland) · 2026

Retrospective Analysis of the Epidemiology and Risk Factors for Recurrent Biliary-Source Bloodstream Infections in Oncologic Patients.

Maffezzoli Paola, Grafia Ignacio, Banús Mar Cusó, Gutiérrez-Santos Aina, Fernández Alba, Peris Ana, Llobera Laia, Quesada Maria Dolores, Buccione Daniela, Corcione Silvia, Tudela Carolina, Bracke Carme, Esquerrà Anna, Romero Alba, Cerdà Gabriela, Benítez Rosa, Mateu Aina, Sales Anna, Soriano Alex, Paredes Roger, Cardona Pere-Joan, De Rosa Francesco Giuseppe, Pedro-Botet María Luisa, Puerta-Alcalde Pedro

СтатьяПеревод в очереди

Аннотация

Background

We aimed to describe the clinical and microbiological characteristics of biliary-source bloodstream infections (bBSIs) in patients with malignancies and identify risk factors for recurrence.

Methods

All bBSI episodes in patients with active solid tumors during 2021-2025 were retrospectively reviewed. Independent risk factors for recurrent bBSI and mortality were identified. A previously published recurrence risk score was externally validated.

Results

Overall, 136 patients experienced 199 bBSI episodes. Pancreatic (36.7%) and biliary tract (33.2%) were the most common cancers, and 60.8% had metastatic disease. The main pathogens were Escherichia coli (43.2%), Klebsiella pneumoniae (24.1%), and Enterococcus faecium (19.1%), and multidrug-resistant organisms accounted for 19.1%. Inappropriate empirical antibiotic treatment (IEAT) occurred in 37.2% and was independently associated with increased 30-day mortality, together with metastatic disease and septic shock. Thirty-day mortality was 24.6%. Recurrent bBSI occurred in 35.7% and was independently associated with biliary tract cancer, previous multidrug-resistant isolation, and prior hospitalization for suspected biliary infection. The externally validated recurrence score showed excellent discrimination (AUC 0.815).

Conclusions

bBSI in oncology patients is associated with high rates of MDR pathogens, IEAT, recurrence, and mortality. A simple clinical score may identify patients at high risk of recurrence and guide preventive strategies.

Для цитирования: Maffezzoli Paola, Grafia Ignacio, Banús Mar Cusó, Gutiérrez-Santos Aina, Fernández Alba, Peris Ana, Llobera Laia, Quesada Maria Dolores, Buccione Daniela, Corcione Silvia, Tudela Carolina, Bracke Carme, Esquerrà Anna, Romero Alba, Cerdà Gabriela, Benítez Rosa, Mateu Aina, Sales Anna, Soriano Alex, Paredes Roger, Cardona Pere-Joan, De Rosa Francesco Giuseppe, Pedro-Botet María Luisa, Puerta-Alcalde Pedro. Retrospective Analysis of the Epidemiology and Risk Factors for Recurrent Biliary-Source Bloodstream Infections in Oncologic Patients.. Antibiotics (Basel, Switzerland). 2026. DOI: 10.3390/antibiotics15040342.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.